Standard of care: Promoting antiretroviral adherence in clinical care

被引:19
作者
Harman, JJ [1 ]
Amico, KR [1 ]
Johnson, BT [1 ]
机构
[1] Univ Connecticut, Dept Psychol, Ctr Hlth & HIV Intervent & Prevent, Storrs, CT 06269 USA
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2005年 / 17卷 / 02期
关键词
D O I
10.1080/09540120512331325707
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Although there has long been demand for programs and procedures that support or enhance adherence to antiretroviral therapy ( ART) among HIV+ patients, there is scant evidence about the extent to which medical clinics have been able to incorporate adherence interventions into their standard care. A survey of clinical care settings in New York and Connecticut indicated that the current standard of care is to provide only minimal levels of adherence services, with ad hoc adherence support being offered on an as-needed basis, often by overburdened primary care staff. These results suggest a strong need for the development of ART adherence interventions that are not only easily translatable to real-life clinical settings, but also offer an organized compendium of resources for HIV+ patients, from initiation to maintenance.
引用
收藏
页码:237 / 251
页数:15
相关论文
共 35 条
  • [1] The era of adherence to HIV therapy
    Altice, FL
    Friedland, GH
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (06) : 503 - 505
  • [2] Progress in hiv therapeutics and the challenges of adherence to antiretroviral therapy
    Andrews, L
    Friedland, G
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2000, 14 (04) : 901 - +
  • [3] Antiretroviral adherence issues among HIV-positive adolescents and young adults
    Belzer, ME
    Fuchs, DN
    Luftman, GS
    Tucker, DJ
    [J]. JOURNAL OF ADOLESCENT HEALTH, 1999, 25 (05) : 316 - 319
  • [4] Adherence to highly active antiretroviral therapy in the real world: experience of twelve English HIV units
    Brook, MG
    Dale, A
    Tomlinson, D
    Waterworth, C
    Daniels, D
    Forster, G
    [J]. AIDS PATIENT CARE AND STDS, 2001, 15 (09) : 491 - 494
  • [5] *CDC, 2002, CDC SURV REP DEC 200
  • [6] CHESNEY MA, 2003, ADHERENCE LONG TERM, P95
  • [7] Cinti S K, 2000, AIDS Read, V10, P709
  • [8] Cohn SE, 2001, J ACQ IMMUN DEF SYND, V28, P385, DOI 10.1097/00126334-200112010-00013
  • [9] CONWAY B, 1997, INT WORKSH HIV DRUG
  • [10] Crane L, 2002, J ACQ IMMUN DEF SYND, V30, P21, DOI 10.1097/00126334-200205010-00003